Perfusion abnormalities in prodromal AD

Neurobiology of Aging

Volumn 21, Issue 2, 2000, Pages 289-292

  Johnson, Keith A ^a,b   Albert, Marilyn S ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer; Dementia; Perfusion; PET; Radionuclide imaging; SPECT

Indexed keywords

RADIOISOTOPE;

ALZHEIMER DISEASE; AMNESIA; BRAIN PERFUSION; BRAIN REGION; CONFERENCE PAPER; DISEASE COURSE; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; HUMAN; IMAGING; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX;

ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; HUMANS;

EID: 0034603511     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00137-8     Document Type: Conference Paper

References (43)

1. Albert M, Jones K, Moss M, Tanzi R. Preclinical prediction of AD using neuropsychological tests. Submitted.
2. Arikuni T., Sako H., Murata A. Ipsilateral connections of the anterior cingulate cortex with the frontal and medial temporal cortices in the macaque monkey. Neurosci Res. 21:1994;19-39.
3. Ball M.J. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol. 37:1977;111-118.
4. Corder E., Jelic V., Basun H., et al. No difference in cerebral glucose metabolism in patients with Alzheimer's disease and differing apolipoprotein E genotypes. Arch Neurol. 54:1997;273-277.
5. Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting 'conversion' to AD using standardized clinical information. Arch Neurol. In press.
6. DeKosky S., Shih W.-J., Schmitt F., Coupal J., Kirkpatrick C. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer's disease correlation with cognitive severity . Alzheimer's Dis Assoc Disord. 4:1990;14-23.
7. Duara R., Grady C., Haxby J., et al. Positron emission tomography in Alzheimer's disease. Neurology. 36:1986;879-887.
8. Farkas T., Ferris S.H., Wolf A.P., De Leon M.J., Christman D.R., Reisberg B., Alavi A., Fowler J.S., George A.E., Reivich M. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. Am J Psychiatry. 139:1982;352-353.
9. Foster N.L., Chase T.N., Mansi L., et al. Cortical abnormalities in Alzheimer's disease. Ann Neurol. 16:1984;649-654.
10. Friedland R.P., Budinger T.F., Ganz E., et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type positron emission tomography with [18F]fluorodeoxyglucose . J Comput Assist Tomogr. 7:1983;590-598.
11. Gómez-Isla T., Price J.L., McKeel D.W. Jr, Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 16:1996;4491-4500.
12. Gómez-Isla T., Hollister R., West H., et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 41:1997;17-24.
13. Higuchi M., Arai H., Nakagawa T., et al. Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease. Neuroreport. 8:1997;2639-2643.
14. Holman B.L., Johnson K.A., Gerada B., Carvalho P.A., Satlin A. The scintigraphic appearance of Alzheimer's disease a prospective study using technetium-99m-HMPAO SPECT . J Nucl Med. 33:1992;181-185.
15. Hyman B.T., Van Horsen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease cell-specific pathology isolates the hippocampal formation . Science. 225:1984;1168-1170.
16. Jobst K., Barneston L., Shepstone B. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia the use of NINCDS-ADRDA and DSM III-R criteria, SPECT, X-ray CT and APOE4 medial temporal lobe dementias . Int Psychogeriatr. 9:1997;191-222.
17. Johnson K.A., Kijewski M.F., Becker J.A., Garada B., Satlin A., Holman B.L. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med. 34:1993;2044-2048.
18. Johnson KA, Lopera F, Jones K, et al. Presenilin-1-associated abnormalities in regional cerebral perfusion. Society for Neuroscience, Annual Meeting, Los Angeles, CA, 1998a.
19. Johnson K.A., Jones K.J., Becker J.A., Satlin A., Holman B.L., Albert M.S. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 50:1998b;1563-1571.
20. Kennedy A.M., Frackowiak R.S., Newman S.K., et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett. 186:1995;17-20.
21. Lafleche G., Albert M. Executive function deficits in mild Alzheimer's disease. Neuropsychology. 9:1995;313-320.
22. Lehtovirta M., Kuikka J., Helisalmi S., et al. Longitudinal SPECT study in Alzheimer's disease relation to apolipoprotein E polymorphism . J Neurol Psychiatry. 64:1998;742-746.
23. McGeer E.G., McGeer P.L., Harrop R., Akiyama H., Kamo H. Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's disease. J Neurosci Res. 27:1990;612-619.
24. Meguro K., Blaizot X., Kondoh Y., LeMestric C., Baron J., Chavoix C. Neocortical and hippocampal glucose metabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate. Brain. 2:1999;1519-1531.
25. Minoshima S., Foster N.L., Kuhl D.E. Posterior cingulate cortex in Alzheimer's disease. [letter] Lancet. 344:1994;895.
26. Minoshima S., Frey K., Koeppe R., Foster N., Kuhl D. A diagnostic approach to Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 36:1995;1238-1248.
27. Moss M.B., Albert M.S., Butters N., Payne M. Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol. 43:1986;239-246.
28. Pandya D.N., Seltzer B. Intrinsic connections and architectonics of posterior parietal cortex in the rhesus monkey. Comp Neurol. 204:1982;196-210.
29. Reiman E.M., Caselli R.J., Yun L.S., et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein Ev. N Engl J Med. 334:1996;752-758.
30. Saunders A.M., Hulette O., Welsh-Bohmer K.A., et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet. 348:1996;90-93.
31. Small G.W., Mazziotta J.C., Collins M.T., et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. J Am Med Assoc. 273:1995;942-947.
32. Smith G.S., de Leon M.J., George A.E., et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch Neurol. 49:1992;1142-1150.
33. Sperling R., Jones K., Rentz D., et al. SPECT cerebral perfusion and apolipoprotein E genotype. Neurology. 58:1998;S70.
34. Stern Y., Tang M.-X., Albert M., et al. Predicting time to nursing home care and death in individuals with Alzheimer's disease. J Am Med Assoc. 277:1997;806-812.
35. Sutherland R.J., Rudy J.W. Configurational association theory the role of the hippocampal formation in learning, memory, and amnesia . Psychobiology. 17:1989;129-144.
36. Sutherland R.J., Rudy J.W. Exceptions to the rule of space. Hippocampus. 1:1991;250-252.
37. van Dyck C., Gelernter J., MacAvoy M., et al. Absence of an apolipoprotein E epsilon4 allele associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer's disease. Arch Neurol. 55:1998;1460-1466.
38. Van Hoesen G.W., Hyman B.T., Damasio A.R. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus. 1:1991;1-8.
39. Van Hoesen G.W., Solodkin A. Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease. Cereb Cortex. 3:1993;465-475.
40. Vogt B.A., Pandya D.N., Rosene D.L. Cingulate cortex of the rhesus monkey. I. Cytoarchitecture and thalamic afferents. J Comp Neurol. 262:1987;256-270.
41. Vogt B.A., Crino P.B., Volicer L. Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease. J Neurochem. 57:1991;282-290.
42. Welsh K.A., Butters N., Hughes J.P., Mohs R.C., Heyman A. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol. 49:1992;448-452.
43. Zola S., Squire L., Teng E., Stefanacci L., Bufallo E., Clark R. Impaired recognition memory in monkeys after damage limited to the hippocampal region. J Neuroscience. 20:2000;451-463.